Servier Tianeptine Controversy: Difference between revisions
m AnotherConsumerRightsPerson moved page Servier - Tianeptine Controversy to Servier Tianeptine Controversy: Dash isn’t needed. |
Deletion request. Complete lack of references, overly complex jargon (breaking the granny rule), and might actually be AI. Additionally, a controversy is not an incident. Article is written more like a warning against a controversial drug that is *already illegal* in the US. Article is entirely irrelevant. |
||
| (One intermediate revision by one other user not shown) | |||
| Line 1: | Line 1: | ||
{{InfoboxProductLine | {{DeletionRequest|Complete lack of references, overly complex jargon (breaking the granny rule), and might actually be AI. Additionally, a controversy is not an incident. Article is written more like a warning against a controversial drug that is *already illegal* in the US. Article is entirely irrelevant.}}{{InfoboxProductLine | ||
| Title = {{PAGENAME}} | | Title = {{PAGENAME}} | ||
| Release Year =1983 | | Release Year =1983 | ||
| Line 9: | Line 9: | ||
Tianeptine is a drug marketed as an antidepressant by the | Tianeptine is a drug marketed as an antidepressant by the French company Servier. Tianeptine has opioid like effects, leading to potential dependence and addiction. | ||
==Mechanism of Action Controversy== | ==Mechanism of Action Controversy== | ||